RELIEF THERAPEUTICS Holding SA
Providing relief to patients with unmet medical needs in select specialty and rare diseases.
Geneve, Switzerland
9 employees
Post Ipo Equity
Total: $82.50M
Biotechnology, Pharmaceutical
General Information
Get notified when RELIEF THERAPEUTICS Holding SA moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track RELIEF THERAPEUTICS Holding SA
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Switzerland Market
Biotechnology
About RELIEF THERAPEUTICS Holding SA
Taxonomy: biopharmaceutical company, therapeutic relief, rare diseases, metabolic disorders, pulmonary diseases, dermatology, connective tissue disorders, genetic diseases, treatment paradigms, efficacy, safety, convenience, unmet medical needs, specialty diseases
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | •••••• | 1 |
|
28 Feb 2024 |
| Post-IPO Equity | •••••• | - | 16 Jun 2023 | |
| Post-IPO Equity | •••••• | - | 26 Jul 2021 | |
| Post-IPO Equity | •••••• | - | 12 Mar 2021 | |
| Series A | •••••• | 1 |
|
24 May 2016 |
RELIEF THERAPEUTICS Holding SA Alternatives & Competitors
A clinical-stage biopharmaceutical company focused on central nervous system disorders and rare dise...
Rewriting RNA
Focused on every detail, making sure our services exceed the expectations of our patients, providers...
FAQ About RELIEF THERAPEUTICS Holding SA
Don't just browse. Track.
Signal Tracker monitors RELIEF THERAPEUTICS Holding SA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
